Acology Poised to Take Advantage of Federal CARERS Act
June 07 2016 - 8:06AM
InvestorsHub NewsWire
SOURCE: Acology Inc.; D & C Distributors
LLC
|
CORONA, CA--(NewMediaWire - Jun 7, 2016) - Acology Inc.
(OTC PINK: ACOL) has published a position paper that
outlines the company's unique position to take advantage of the
passage of the Federal Government's CARERS Act later this year.
(Knowledge Eclipse: Acology Looks Confidently Ahead to
Repeal)
Having sold more than 600,000 units in the United States and
Canada in the last 24 months Acology has positioned itself and its'
signature product, The MedTainerâ„¢, as the categorically best and
most compliant packaging, labeling and tracking container in the
medical and recreational MJ Industry, fulfilling requirements for
safe packaging in more than 30 States and every Canadian Province.
Acology also asserts that it has successfully anticipated eventual
US federal guidelines for safe, certified child-resistant medical
and recreational MJ packaging. Acology and the MedTainer have
created a distinctive, valuable niche in this fast-expanding
market. This market includes all of North America, as the Canadian
Federal Government has begun to look closely at safety-compliant
packaging and The MedTainer is currently selling tens of thousands
of units in that country.
The US is now considering The Compassionate Access, Research
Expansion and Respect State Act (CARERS). This is by far the most
comprehensive piece of federal medical marijuana legislation ever
produced in Congress. This bi-partisan bill would finally remedy
the state-federal conflicts over medical marijuana law with
far-reaching effects. Among these would be the long-anticipated
reduction of cannabis and CBDs from the current Schedule 1 Narcotic
classification. Importantly, it will also create a banking
mechanism for legal marijuana businesses to process deposits and
profits. This in turn will open the door for the rapid expansion of
businesses, like Acology Inc. that have established relationships
with companies that are ready to take advantage of what will prove
to be an immense financial opportunity.
This press release includes statements that are covered by the
Private Securities Litigation Reform Act of 1995. Because such
statements deal with future events they are subject to risks and
uncertainties and actual results for fiscal year 201 and beyond
could differ materially from the company's current expectations.
Forward-looking statements are identified by such words as
"anticipates", "projects", "expects", "planned", "intends" and
"believes", "estimate", "targets" and other similar expressions
that indicate trends and future events. It is understood that
investment entails risk on the part of the investor and could
result in the loss of some or all of his or her investment.
Acology Inc. and D&C Distributors are located in their new
production and distribution facility at 1630 Commerce St. Corona,
California, 92880. Acology trades on the OTC under the call letters
ACOL. The company's emails are www.theMedtainer.com for the medical and
recreational MJ industry and www.Acologyinc.com for the hospice and
palliative care industry.
CONTACT INFORMATION
Please send inquiries to
Acology Inc.
info@acologyinc.com
or call (844) ACOLOGY (844-226-5649) Ext. 3